Benitec Biopharma, Inc.(NASDAQ : BNTC)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||-1.04%||69.70||1.0%||$466.79m|
|REGN||Regeneron Pharmaceuticals, Inc.||2.34%||625.50||2.7%||$405.44m|
|VRTX||Vertex Pharmaceuticals, Inc.||0.32%||231.81||1.9%||$335.28m|
|SNSS||Sunesis Pharmaceuticals, Inc.||0.33%||3.01||0.7%||$210.41m|
|EXAS||EXACT Sciences Corp.||1.40%||78.51||17.9%||$156.33m|
|ARNA||Arena Pharmaceuticals, Inc.||-0.39%||91.62||13.7%||$144.85m|
|ALNY||Alnylam Pharmaceuticals, Inc.||0.68%||140.13||8.2%||$140.06m|
|BMRN||BioMarin Pharmaceutical, Inc.||0.75%||87.36||4.2%||$107.00m|
Benitec Biopharma, Inc. is a development-stage biotechnology company, which focuses on the advancement of novel genetic medicines. The firms proprietary platforms includes DNA-directed RNA interference, or ddRNAi, combines RNA interference, or RNAi, with gene therapy to create medicines that facilitates sustained silencing of disease-causing genes following a single administration. It is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy, and Chronic Hepatitis B. The company was founded on November 22, 2019 and is headquartered in Hayward, CA.